High somatic mutations in circulating tumor DNA predict response of metastatic pancreatic ductal adenocarcinoma to first-line nab-paclitaxel plus S-1: prospective study
2024 · Journal of Translational Medicine · 12 citations
https://doi.org/10.1186/s12967-024-04989-z